A phase II randomized trial in completely resected non-small cell lung cancer comparing paclitaxel / carboplatin with TS-1
Not Applicable
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000001510
- Lead Sponsor
- agoya City University thoracic oncology study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) apparent interstitial pneumonitis or pulmonary fibrosis 2) uncontroled pleural effusion or ascitis 3) multiple lung cancer 4) concomittant malignanct 5) past history of radiotherapy or chemotherapy 6) active infection or uncontroled complication 7) past history of severe allergic reaction 8) Pregnant or expecting woman 9) other conditions not suitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2-year relapse free survival
- Secondary Outcome Measures
Name Time Method